BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 31, 2003
View Archived Issues
FDA Response Letter Seen As Positive Sign For MedImmune
A complete response letter from the FDA regarding FluMist has elicited a positive reaction at MedImmune Inc., which also reported record revenue as part of its fourth-quarter and year-end earnings. (BioWorld Today)
Read More
Affymetrix Signs $70M GeneChip Deal With Roche Diagnostics
Read More
As West Nile Encephalitis Virus Blankets North America, Authors Seek To Disarm Immune Attacks
Read More
Corixa, GSK Changing Terms Of Cancer Vaccine Agreement
Read More
Biotech Reps Square Off With Feds Over Reimbursement Rates
Read More
Elan Continues Divestiture With Product Sales To King
Read More
Other News To Note
Read More